Delores Lindh

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

Irwin Hollander, I. Bernstein, H. Tsou, 2002, Bioconjugate chemistry.

An anti-MUC1 antibody-calicheamicin conjugate for treatment of solid tumors. Choice of linker and overcoming drug resistance.

Ana T Menendez, L. Greenberger, F. Durr, 2005, Bioconjugate chemistry.